(VRNA) Verona Pharma - Performance 266% in 12m
Compare VRNA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
90.72%
#1 in Group
Rel. Strength
99.24%
#62 in Universe
Total Return 12m
265.96%
#2 in Group
Total Return 5y
1203.86%
#2 in Group
P/E -
(?) Percentile in Group
P/E Forward 357
94th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -1.77%
(?) Percentile in Group
12m Total Return: VRNA (266%) vs XLV (-0.5%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
| LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
| NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
| SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
| SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
| SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
| NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: VRNA vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for VRNA
| Total Return (including Dividends) | VRNA | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -7.29% | -7.37% | -5.89% |
| 3 Months | 10.13% | -4.55% | -12.45% |
| 12 Months | 265.96% | -0.54% | 6.72% |
| 5 Years | 1203.86% | 46.59% | 101.06% |
| Trend Score (consistency of price movement) | VRNA | XLV | S&P 500 |
| 1 Month | -74.4% | -82.6% | -74.5% |
| 3 Months | 15.4% | -37.8% | -88.2% |
| 12 Months | 97.3% | -1.6% | 66.1% |
| 5 Years | 80.4% | 90.1% | 84.3% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #74 | 0.09% | -1.49% |
| 3 Month | #21 | 15.4% | 25.8% |
| 12 Month | #2 | 268% | 243% |
| 5 Years | #3 | 789% | 548% |
FAQs
Does VRNA Verona Pharma outperforms the market?
Yes,
over the last 12 months VRNA made 265.96%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months VRNA made 10.13%, while XLV made -4.55%.
Over the last 3 months VRNA made 10.13%, while XLV made -4.55%.
Performance Comparison VRNA vs Indeces and Sectors
VRNA vs. Indices VRNA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.51% | -1.40% | 79.5% | 259% |
| US NASDAQ 100 | QQQ | 4.37% | -1.01% | 80.1% | 260% |
| US Dow Jones Industrial 30 | DIA | 4.68% | -1.47% | 79.0% | 261% |
| German DAX 40 | DAX | -1.85% | 2.11% | 62.5% | 248% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.80% | 0.21% | 77.2% | 260% |
| Hongkong Hang Seng | HSI | -0.78% | 2.53% | 78.0% | 250% |
| India NIFTY 50 | INDA | -0.86% | -12.1% | 77.1% | 263% |
| Brasil Bovespa | EWZ | -0.05% | -2.21% | 76.6% | 275% |
VRNA vs. Sectors VRNA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.26% | -1.63% | 70.7% | 252% |
| Consumer Discretionary | XLY | 4.38% | -3.37% | 76.8% | 257% |
| Consumer Staples | XLP | 0.21% | -10.5% | 69.3% | 252% |
| Energy | XLE | -1.21% | 2.79% | 78.5% | 276% |
| Financial | XLF | 2.14% | -2.78% | 71.4% | 247% |
| Health Care | XLV | 3.11% | 0.08% | 80.9% | 267% |
| Industrial | XLI | 2.39% | -2.59% | 79.4% | 261% |
| Materials | XLB | 1.79% | -0.64% | 86.6% | 274% |
| Real Estate | XLRE | -1.83% | -4.40% | 78.2% | 249% |
| Technology | XLK | 4.87% | 1.64% | 86.3% | 267% |
| Utilities | XLU | 0.20% | -6.87% | 73.8% | 242% |
| Aerospace & Defense | XAR | 1.82% | -7.33% | 69.8% | 242% |
| Biotech | XBI | -0.05% | 4.59% | 94.1% | 275% |
| Homebuilder | XHB | 2.56% | -0.45% | 97.4% | 275% |
| Retail | XRT | 1.81% | -5.18% | 84.2% | 270% |